Radiomics - the next era of possibilities in Precision Medicine
Traditionally medical image analysis has been done through visual interpretation of static images. In the past decade, with the advent of sophisticated measurement tools, it has become possible to…
Radiologist’s AI-powered workflow
We all have been exposed to the riveting news of artificial intelligence tools taking over diagnostic imaging. Due to the rapid increase in global drivers such as aging population, new government…
Mint Medical and Agfa HealthCare announce seamless integration of mint Lesion and ORBIS RIS at RSNA 2018
Heidelberg, Bonn, GER - At this year’s Radiological Society of North America (RSNA) Annual Meeting 2018, Agfa HealthCare and Mint Medical will announce a seamless integration of ORBIS RIS and mint…
mint PI-RADS V2 report as the standard for communication with urologists - Interview with PD Dr. Röthke
Since the beginning of 2017, all PI-RADS v2 reads are exclusively performed with mint Lesion™ by PD Dr. Matthias Röthke, Chief Medical Officer at Conradia in Hamburg. In this interview, he…
Pancreas staging in clinical routine at University Hospital Innsbruck - Interview with PD Dr. Widmann
The University Hospital in Innsbruck, Austria, has been using mint Lesion™ since mid-2015 with the initial focus on clinical trials in order to guarantee the conformity with the guidelines defined…
Assessment time halved: Importance of a good tumor response assessment tool in clinical site reads
The Clinical Research Imaging Core (CRIC) of the University of Wisconsin Carbone Cancer Center (UWCCC) recently published a poster at the AACI CRI conference titled “Shared Investment to Build a…
Study - free text reporting vs. mint Lesion in clinical routine
Free text reporting in the tumor response assessment of radiologic imaging data is common in clinical routine, whereas in clinical trials standardized computer-aided response assessment is already…
6 years of Mint at University Hospital Basel - Interview with PD Dr. Tobias Heye
Since the end of 2011, mint Lesion™ has been in use at the University Hospital in Basel, Switzerland, – initially merely as a tool for clinical trials, but now also as the standard instrument for…
New iRECIST whitepaper published
We are happy to present our newly published whitepaper on iRECIST and its application. This is available here on our homepage as well as on www.irecist.com. Mint Medical had already implemented the…
University Hospital Ulm: Pilot study shows discriminatory power of MRI-based 3d texture analysis for bone lesions
Distinguishing between enchondroma, a benign tumor, and low-grade chondrosarcoma, which is a low-aggressivity malignancy, is a frequent challenge, as the lesions are both histologically and…